Weiss Multi-Strategy Advisers’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-29,304
Closed -$2.43M 690
2023
Q1
$2.43M Sell
29,304
-87,748
-75% -$7.27M 0.06% 395
2022
Q4
$10M Buy
117,052
+6,533
+6% +$517K 0.29% 112
2022
Q3
$6.82M Buy
110,519
+53,813
+95% +$3.39M 0.18% 182
2022
Q2
$3.5M Buy
+56,706
New +$3.51M 0.11% 293
2020
Q1
Sell
-20,000
Closed -$1.3M 502
2019
Q4
$1.3M Buy
20,000
+5,000
+33% +$326K 0.02% 466
2019
Q3
$951K Buy
15,000
+7,000
+88% +$458K 0.02% 452
2019
Q2
$540K Hold
8,000
0.01% 416
2019
Q1
$520K Hold
8,000
0.01% 434
2018
Q4
$500K Hold
8,000
0.02% 348
2018
Q3
$618K Buy
+8,000
New +$604K 0.02% 427
2017
Q4
Sell
-50,000
Closed -$4.05M 596
2017
Q3
$4.05M Buy
50,000
+24,658
+97% +$1.89M 0.15% 197
2017
Q2
$1.79M Buy
25,342
+15,191
+150% +$1.01M 0.08% 303
2017
Q1
$689K Sell
10,151
-2,474
-20% -$174K 0.03% 428
2016
Q4
$904K Buy
12,625
+14
+0.1% +$1.04K 0.04% 283
2016
Q3
$998K Buy
12,611
+1,524
+14% +$124K 0.06% 290
2016
Q2
$925K Sell
11,087
-9,365
-46% -$831K 0.07% 270
2016
Q1
$1.88M Buy
20,452
+8,007
+64% +$722K 0.08% 275
2015
Q4
$1.26M Buy
+12,445
New +$1.29M 0.09% 218
2015
Q3
Sell
-5,430
Closed -$636K 433
2015
Q2
$636K Buy
+5,430
New +$593K 0.03% 358
2014
Q4
Sell
-45,000
Closed -$4.79M 448
2014
Q3
$4.79M Sell
45,000
-15,770
-26% -$1.54M 0.12% 203
2014
Q2
$5.04M Sell
60,770
-51,510
-46% -$4.01M 0.11% 210
2014
Q1
$7.96M Sell
112,280
-33,210
-23% -$2.6M 0.16% 165
2013
Q4
$10.9M Buy
145,490
+86,160
+145% +$6M 0.24% 126
2013
Q3
$3.73M Buy
59,330
+24,330
+70% +$1.45M 0.08% 257
2013
Q2
$1.79M Buy
+35,000
New +$1.82M 0.05% 331

Other funds holding GILD

Weiss Multi-Strategy Advisers's GILD Position: Q2 2023 in Review

Weiss Multi-Strategy Advisers sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 29,304 shares — an estimated $2.43M sold.

Weiss Multi-Strategy Advisers first reported a position in GILD in Q2 2013 and held it in 25 quarters. The position peaked at $10.9M in Q4 2013. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 29,304 Gilead Sciences shares in Q2 2023, an estimated $2.43M.
  • Weiss Multi-Strategy Advisers first reported a position in Gilead Sciences in Q2 2013 and held it in 25 quarters.
  • Weiss Multi-Strategy Advisers's Gilead Sciences position peaked at $10.9M in Q4 2013.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.